biolog comparison wild-typ zidovudine-resist isol human immunodefici viru type subject suscept resist drug viral endpoint dilut chang proport zidovudin azidothymidin azt virus heterogen mixtur human immunodefici viru type quasispeci patient long-term azt therapi sever isol microm azt suscept novel cytosin analog sulfur atom carbon pentos ring certain instanc cross-resist strain azt-resist display suscept strain case 